Ivim Health GLP-1 prices
Membership telehealth ($74.99 a month on top of the medication) selling compounded semaglutide and tirzepatide, and brand Zepbound, the Wegovy pill and Foundayo at the manufacturers' self-pay prices. Ivim Health has 5 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $224.99/mo ($150 medication + $74.99 ongoing membership/provider fee); Compounded tirzepatide $324.99/mo ($250 medication + $74.99 ongoing membership/provider fee); Foundayo $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee); Wegovy pill $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee); Zepbound KwikPen $373.99/mo ($299 medication + $74.99 ongoing membership/provider fee). Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.
Search by medication, provider or treatment goal. Examples follow.
5 offers · US self-pay · 3 maintenance quotes
- Foundayo via Ivim Health
Orforglipron · Telehealth (branded)
Advertised price$223.99/moCalculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance price$373.99/moView offerAt 17.2 mg
Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Price conditions & source
Maintenance terms: $299 of medication from 9 mg up; $199 at 5.5 mg.
A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source - Wegovy pill via Ivim Health
Semaglutide · Telehealth (branded)
Advertised price$223.99/moCalculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance price$373.99/moView offerAt 25 mg
Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Price conditions & source
A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source - Zepbound KwikPen via Ivim Health
Tirzepatide · Telehealth (branded)
Advertised price$373.99/moCalculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance price$523.99/moView offerAt 15 mg
Calculated: $449 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Price conditions & source
Maintenance terms: Ivim lists $449 of medication at 7.5 to 15 mg, for vials and KwikPens alike.
A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source - Advertised price$224.99/mo
Calculated: $150 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
1-month program. On 12 months the medication is $780 ($65 a month) plus $899.88 of membership, $1,679.88 in all; compounded programs are paid upfront and the membership runs for the whole plan. Other Ivim pages show $75, $140 or $149 a month for semaglutide. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source - Advertised price$324.99/mo
Calculated: $250 medication + $74.99 ongoing membership/provider fee. Charges billed separately.
Separate billing cycles; excluded from cost ranking.
Checked
Maintenance priceView offerNo separate dose price verified
Price conditions & source
1-month program. On 12 months the medication is $1,400 (about $117 a month) plus $899.88 of membership, $2,299.88 in all, paid upfront. Other Ivim pages show $133 or $192 a month for tirzepatide. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
Ivim Health GLP-1 cost: common questions
How much does semaglutide cost through Ivim Health?
Compounded semaglutide: $224.99/mo ($150 medication + $74.99 ongoing membership/provider fee). Wegovy pill: $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee); $373.99/mo ($299 medication + $74.99 ongoing membership/provider fee) at 25 mg. Checked Oct 17, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through Ivim Health?
Compounded tirzepatide: $324.99/mo ($250 medication + $74.99 ongoing membership/provider fee). Zepbound KwikPen: $373.99/mo ($299 medication + $74.99 ongoing membership/provider fee); $523.99/mo ($449 medication + $74.99 ongoing membership/provider fee) at 15 mg. Checked Oct 17, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.
How much does orforglipron cost through Ivim Health?
Foundayo: $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee); $373.99/mo ($299 medication + $74.99 ongoing membership/provider fee) at 17.2 mg. Checked Oct 17, 2026; each quote links its source in the table.
Does Ivim Health offer FDA-approved GLP-1 medication or compounded versions?
Both are tracked here. FDA-approved products: Foundayo; Wegovy pill; Zepbound KwikPen. Compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
Do Ivim Health prices include the medication?
The totals shown here add the medication price and the provider's own fee. Compounded semaglutide: $224.99/mo ($150 medication + $74.99 ongoing membership/provider fee). Compounded tirzepatide: $324.99/mo ($250 medication + $74.99 ongoing membership/provider fee). Foundayo: $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee). Wegovy pill: $223.99/mo ($149 medication + $74.99 ongoing membership/provider fee). Zepbound KwikPen: $373.99/mo ($299 medication + $74.99 ongoing membership/provider fee).
When were Ivim Health prices last checked?
Each quote carries its own check date and links the page it was read from: Oct 17, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.